Results 251 to 260 of about 58,634 (303)

Percutaneous management and outcomes of outflow graft obstruction in patients with left ventricular assist device: A single-center experience. [PDF]

JHLT Open
Wu Y, Baudart S, Cheng R, Kallianos K, Ruaysungnoen R, DesJardin J, Aras M, Soni K, Fiedler A, Smith J, Klein L.   +10 more
europepmc   +1 more source

Chronic kidney disease following left ventricular assist device implantation: contemporary insights and future perspectives. [PDF]

Heart Fail Rev
Alvarez-Echeverry I, Guven G, Jahangiri P, Hesselink DA, Soliman O, Rajapreyar I, Rame JE, Ince C, Caliskan K.   +8 more
europepmc   +1 more source

Durable left ventricular assist device pump stoppage due to rotor dysfunction. [PDF]

JTCVS Tech
Madira S, Rahimi M, Schumer E, Schill M, Sullivan M, Hartupee J, Ewald G, Kotkar K, Masood MF, Pawale A.   +9 more
europepmc   +1 more source

A scenario of left ventricular assist device suction mimicking external compression. [PDF]

Indian J Thorac Cardiovasc Surg
Bezak B, Artemiou P, Ondrusek M, Durdik S, Gasparovic I, Hulman M.   +5 more
europepmc   +1 more source

High-volume centers achieve superior outcomes in left ventricular assist device explant-heart transplantation. [PDF]

JTCVS Open
McGeoch CLB, Rust CJ, Kodimerla R, El Sammak S, Mylonas KS, Naqvi H, Randhawa SS, Tang A, Halkos ME, Bishawi MM, Daneshmand MA, Chan JL.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Implantable Left Ventricular Assist Devices

New England Journal of Medicine, 1998
Congestive heart failure affects about 1 percent of adults in the United States1 and is a contributing factor in over 250,000 deaths annually.2 It is diagnosed in 400,000 Americans each year3 and is the primary diagnosis for over 900,000 hospitalizations per year.4 In 1990 the age-adjusted death rate from congestive heart failure was 106.4 per 100,000 ...
D J, Goldstein, M C, Oz, E A, Rose
openaire   +2 more sources